Case Study

Accelerated ADC Approval Through Expert Modeling and Data Rescue

See how Certara rescued complex ADC PK datasets, delivered PopPK, exposure-response modeling, and enabled rapid…

CertaraDecember 15, 2025

Publication

Pharmacokinetic and bioequivalence of two formulations of Valsartan/Amlodipine Tablet(I) in healthy Chinese volunteers: A randomized, three-period, partially replicated crossover study

Discover how randomized crossover study shows new valsartan/amlodipine formulation is bioequivalent to the reference product,…

CertaraDecember 13, 2025

Case Study

Merck Advances Pediatric Oncology with Innovative ADC Modeling

Merck leveraged ADC modeling and pediatric ADC dose optimization to enable FDA acceptance and advance…

CertaraDecember 12, 2025

Conference

ICoP 2026 India

Danielle PillsburyDecember 11, 2025

Live Events

QSP Workshop 2026 in Japan & Korea – Mastering Scalable AI-enabled QSP modeling software, Certara IQ™

Japan: February 26, 2026 - 1:00 - 5:00 pm | Korea: Wednesday, March 4, 2026…

CertaraDecember 9, 2025

Fact Sheet

Expedited Pharmacometrics Regulatory Submissions

Certara delivers complete, compliant pharmacometric regulatory submission packages in just 4–6 weeks, eliminating the PMx…

CertaraDecember 8, 2025

Publication

Therapeutic drug monitoring of amikacin in Chinese premature infant: a population pharmacokinetic analysis and dosage optimization.

See how PopPK modelling in Chinese premature infants identifies key covariates and supports model‑based amikacin…

CertaraDecember 6, 2025

On-Demand Webinar

PK Report Creation with AI: From Days to Minutes

AI PK Reports, a component of Phoenix Cloud, turns the protocol, data tables and figures…

CertaraDecember 4, 2025

Announcement

Certara Cuts Pharmacometrics Submission Timelines in Half: New Expedited Service Accelerates Global Regulatory Filings

Certara launches an expedited Pharmacometrics (PMx) Regulatory Submission service that cuts submission timelines in half.

CertaraDecember 3, 2025

Publication

Comparative Pharmacokinetics of Lutein and Zeaxanthin from Phospholipid, Liposomal, and MCT Formulations in SD Rats

Learn how phospholipid‑based formulations significantly increased lutein and zeaxanthin exposure versus MCT oil, analysed using…

CertaraDecember 2, 2025

Clinical Pharmacology

Accelerated ADC Approval Through Expert Modeling and Data Rescue

Pharmacokinetic and bioequivalence of two formulations of Valsartan/Amlodipine Tablet(I) in healthy Chinese volunteers: A randomized, three-period, partially replicated crossover study

Merck Advances Pediatric Oncology with Innovative ADC Modeling

ICoP 2026 India

QSP Workshop 2026 in Japan & Korea – Mastering Scalable AI-enabled QSP modeling software, Certara IQ™

Expedited Pharmacometrics Regulatory Submissions

Therapeutic drug monitoring of amikacin in Chinese premature infant: a population pharmacokinetic analysis and dosage optimization.

PK Report Creation with AI: From Days to Minutes

Certara Cuts Pharmacometrics Submission Timelines in Half: New Expedited Service Accelerates Global Regulatory Filings

Comparative Pharmacokinetics of Lutein and Zeaxanthin from Phospholipid, Liposomal, and MCT Formulations in SD Rats

Newsletter sign up

Quick links

Solutions

Contact